Proteins, a main constituent of many new drugs, are large molecules that have a tendency to stick to each other and form clumps during their manufacture. These clumps have been associated with severe immune responses. In at least one case, the inadvertent creation of protein clumps during the processing of a drug to treat anemia caused an immune reaction in about 250 patients that destroyed their ability to produce red blood cells. Those patients now have to receive blood transfusions every few days to replenish these vital cells.
Events such as this led the Food and Drug Administration to call for the development of sensitive and rapid measurement tools that can detect aggregation of protein drugs during the manufacturing phase. To address the problem, NIST researchers hit upon the idea of adapting a technique known as electrospray differential mobility analysis (ES-DMA).
Commonly used to size soot and other aerosols, ES-DMA uses an electric current to vaporize a solution of proteins into tiny charged water droplets, each containing a single protein molecule or protein aggregate. Once these droplets evaporate, the charged proteins and protein aggregates are drawn into an oppositely charged tube. By making controlled adjustments to the voltage of the tube and the velocity of the air flowing through it, researchers can collect particles of a specific size, allowing the proteins and protein aggregates to be precisely sorted and counted.
The NIST team adapted the technique for biopharmaceutical applications. According to researcher Leonard Pease, ES-DMA is tricky to get right, but the NIST team was able to define the conditions needed to electrospray proteins and protein aggregates reliably and repeatedly. NIST scientists favor ES-DMA for its ability to quickly resolve particle sizes differing by as little as 0.2 nanometers, to provide a direct measure of particle size distributions, and to accept bioreactor samples with significantly reduced preparation requirements.
In addition to sizing proteins, Pease said the technique could also be used to accurately size many different types of particles used in medicine, such as the viruses used in the human papillomavirus (HPV) vaccine and gene therapy. “The adaptation of this technology is just one of many excellent examples of how NIST seeks out and works with U.S. industry,” says Willie E. May, director of the NIST Chemical Science and Technology Laboratory.
Citatioin: L. Pease, J. Elliott, D. Tsai, M. Zachariah and M. Tarlov. Determination of protein aggregation with differential mobility analysis: application to IgG antibody. Biotechnology and Bioengineering. Available online at
http://dx.doi.org/10.1002/bit.22017.
Provided by NIST
Related stories:
Candy-coating keeps proteins sweet
Sugar-frosting isn’t just for livening up boring bran flakes; it can also preserve important therapeutic proteins. Researchers at the National Institute of Standards and Technology have developed a fast, inexpensive and effective method for evaluating the sugars pharmaceutical companies use to stabilize protein-drugs for storage at room temperature. The group presented their findings at the 236th American Chemical Society National Meeting and Exposition.
'Nanodrop' Test Tubes Created with a Flip of a Switch
Researchers at the National Institute of Standards and Technology have demonstrated a new device that creates nanodroplet “test tubes” for studying individual proteins under conditions that mimic the crowded confines of a living cell. “By confining individual proteins in nanodroplets of water, researchers can directly observe the dynamics and structural changes of these biomolecules,” says physicist Lori Goldner, a coauthor of the paper published in
Langmuir.
Titanium dioxide -- It slices, it dices ...
Chemists from the National Institute of Standards and Technology and Arizona State University have proposed an elegantly simple technique for cleaving proteins into convenient pieces for analysis. The prototype sample preparation method, detailed recently in
Analytical Chemistry, uses ultraviolet light and titanium dioxide and could be ideal for new microfluidic “lab-on-a-chip” devices designed to rapidly analyze minute amount of biological samples.
Changes in urine could lead to BSE test for live animals
Researchers have demonstrated that protein levels in urine samples can indicate both the presence and progress of Bovine Spongiform Encephalopathy (BSE) disease in cattle. Publishing their findings in BioMed Central's open access journal
Proteome Science, the scientists hope that their discovery might lead to the development of a urine-based test that could prevent the precautionary slaughter of many animals as now occurs when the disease is detected.
Thumbs up -- a tiny ancestral remnant lends developmental edge to humans
Subtle genetic changes that confer an evolutionary advantage upon a species, such as the dexterity characteristic of the human hand, while difficult to detect and even harder to reproduce in a model system, have nevertheless generated keen interest amongst evolutionary biologists. In findings published online in the September 5 edition of the journal
Science, researchers from the U.S. Department of Energy's Lawrence Berkeley National Laboratory and their collaborators, have uncovered a specifically human 13-nucelotide change concealed in the vast three-billion-letter landscape of the human genome.
Infectious, test tube-produced prions can jump the 'species barrier'
Researchers have shown that they can create entirely new strains of infectious proteins known as prions in the laboratory by simply mixing infectious prions from one species with the normal prion proteins of another species. The findings are reported in the September 5th issue of the journal
Cell.
Molecular evolution is echoed in bat ears
Echolocation may have evolved more than once in bats, according to new research from the University of Bristol published this week in
Proceedings of the National Academy of Sciences (PNAS).
Fatal protein interactions may explain neurological diseases
In a collaborative study at the University of California, San Diego, investigators from neurosciences, chemistry and medicine, as well as the San Diego Supercomputer Center (SDSC) have investigated how proteins involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease interact to form unique complexes. Their findings explain why Alzheimer's patients might develop Parkinson's, and vice versa. The new and unique molecular structures they discovered can now be used to model and develop new drugs for these devastating neurological diseases. Their findings will be published in the September 3 issue of
Public Library of Science (PLoS) ONE on September 4, 2008.
